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Articular cartilage function depends on the molecular composition and structure of its extracellular
matrix (ECM). The collagen network (CN) provides cartilage with tensile integrity, but must also remodel
during growth. Such remodeling may depend on matrix molecules interacting with the CN to modulate
the tensile behavior of cartilage. The objective of this study was to determine the effects of increasingly
selective matrix depletion on tensile properties of immature and mature articular cartilage, and thereby
establish a framework for identifying molecules involved in CN remodeling. Depletion of immature car-
tilage with guanidine, chondroitinase ABC, chondroitinase AC, and Streptomyces hyaluronidase markedly
increased tensile integrity, while the integrity of mature cartilage remained unaltered after depletion
with guanidine. The enhanced tensile integrity after matrix depletion suggests that certain ECM compo-
nents of immature matrix serve to inhibit CN interactions and may act as modulators of physiological
alterations of cartilage geometry and tensile properties during growth/maturation.
Articular cartilage is a layer of connective tissue located on the
ends of long bones [1] that normally functions as a load-bearing,
low friction, wear-resistant material, facilitating joint motion
[2,3]. The ability of cartilage to withstand compressive, tensile,
and shear forces depends on the composition and structure of
the extracellular matrix (ECM) [2–4]. The proteoglycan constituent
of the extracellular matrix provides the tissue with a ﬁxed negative
charge that increases the tissue’s propensity to swell and to resist
compressive loading [5,6]. The crosslinked collagen network (CN) re-
sists the swelling tendency of the proteoglycan molecules and pro-
vides the tissue with tensile and shear stiffness and strength
[3,7,8]. In adult cartilage, the tensile modulus and strength have
been attributed primarily to the CN [3,9]. An indirect, but dramatic
contribution of the proteoglycan component to the tensile properties
or cartilage has also been demonstrated. Chondroitinase ABC (C-
ABC) treatment, which speciﬁcally depolymerizes chondroitin and
dermatan sulfate GAG chains [10], resulted in a reduction of the ini-
tial slope of the stress–strain curve [11,12] and an increase in the
overall tensile modulus of cartilage [13–15] and tensile strength in
tendon [16]. In addition, collagen to proteoglycan ratio correlated
strongly with equilibrium tensile modulus of cartilage [17]. Thus,
the load-bearing function of cartilage may depend on the ECM com-
ponents, as well as their ability to transfer stress through intermo-
lecular interactions.
The nature of the interactions among collagen ﬁbrils and be-
tween ﬁbrils and other members of the extracellular matrix to
form a functional CN remains to be established. Sites for covalent
pyridinoline crosslinks, catalyzed by lysyl oxidase, are located both
within and between ﬁbrils, linking collagens type II and IX [18].
Such sites on collagen type IX are a source of covalent interﬁbrillar
bonds [19,20]. Other type of bonds may exist between collagen
type IX and proteoglycans, providing a link between the CN and
the extraﬁbrillar matrix components of cartilage [21,22]. Colla-
gen-binding molecules, including small proteoglycans, such as
decorin and ﬁbromodulin, associate with distinct and speciﬁc
bands at the surface of the collagen ﬁbrils through non-covalent
binding of their core proteins [23] and therefore can be considered
as constituents of the CN. These molecules have been proposed as
functional non-covalent linkages within the ECM [23–26]. Aggre-
can, the major proteoglycan in cartilage, while distinct from the
CN, may also form interactions with the CN through hyaluronic
acid, or its keratan sulfate- and chondroitin sulfate-rich regions
[27–30]. Together, extraﬁbrillar matrix components may mediate
the adherence and sliding between collagen ﬁbrils to modulate
cartilage tissue shape [31–33].
The regulation of collagen ﬁbril synthesis, assembly, and
remodeling suggests that the presence of certain extraﬁbrillar ma-
trix molecules may alter the transfer of forces between collagen ﬁ-
brils and the overall tissue integrity. Various studies suggest that
small proteoglycans that bind to collagen ﬁbrils may have a role
in regulation of collagen ﬁbril length and diameter [34–37] and,
consequently, of tensile integrity of connective tissues [38]. Re-
moval of such components appears to enhance the association of
collagen ﬁbrils from tendon in vitro and in vivo [37,39] and enhance
cartilage repair in vivo [40]. These ﬁndings suggest that a decrease
in certain extraﬁbrillar molecules is necessary to permit the asso-
ciation of collagen segments. In corollary, binding of collagen-bind-
ing molecules to the collagen ﬁbrils competitively inhibits the
accretion of additional collagen segments and, in this way, regu-
lates the growth of collagen ﬁbrils during development
[39,41,42]. A similar mechanismmay be responsible for controlling
the restraining function of the collagen network during cartilage
growth and maturation.
Articular cartilage has distinct needs for remodeling at different
stages of maturation. During prenatal or early postnatal growth
periods, expansion of articular cartilage tissue occurs to accommo-
date the rapidly increasing size of the underlying bones and to
meet the loading demands ex utero [43,44]. At skeletal maturity,
after cessation of growth, articular cartilage homeostasis in terms
of geometry, as well as composition, and function is desirable. It
is possible that different interactions among matrix components
may be preferred at various stages of cartilage tissue maturity to
accommodate the needs of the tissue.
While the exact nature of interactions between collagen ﬁ-
brils and extraﬁbrillar matrix components to form a functional
collagen network remains to be established, cartilage growth
and maturation may depend critically on the modulation of the
CN and cartilage tensile properties. A detailed understanding of
the tensile properties of cartilage may provide insight into
molecular mechanisms that regulate interactions within the CN
and the associated changes in the CN function during growth
as well as in cartilage homeostasis and disease. Thus, the objec-
tive of this study was to determine the effects of increasingly
selective matrix depletion on tensile mechanical properties of
immature and mature articular cartilage, and thereby establish




Articular cartilage blocks, 9  3 mm2 in area, were harvested from the patellofe-
moral groove of bovines that were immature (1–3 week calf, bCALF, n = 3) or were
young adults (1–2 years, bYOUNG, n = 3) and of humans that were teen aged (15–16
years, hTEEN, n = 2) or were skeletally mature adults (37–39 years, hADULT, n = 3).
Bovine joints were obtained from an abattoir and harvested as described previously
[45]. Human donor tissue was obtained from San Diego Life Sharing (San Diego, CA)
within 72 h after death and stored at 70 C. Only normal human articular cartilage
(grade 1A [46]) was used in the study. Cartilage blocks were prepared using a sledge
microtome to either include the intact articular surface (superﬁcial layer, 0.45 mm
thick, S) or to include the middle zone, starting at a distance of 0.6 mm from the
articular surface (middle layer, 0.25 mm thick, M). The long axes of the blocks were
in the anterior–posterior direction [45] and, thus, approximately perpendicular to
the split line direction.
Experimental design
Blocks were weighed wet (WWi), treated, weighed wet again (WWf),
rinsed, tested in tension, and analyzed for biochemical composition as de-
scribed below. All solutions included protease inhibitors (2 mM Na2–EDTA,
1 mM PMSF, 5 mM Benz–HCl, 10 mM NEM). Two series of experiments were
carried out.
Experiment 1
To investigate the effect of non-covalent intermolecular bonds among the extra-
cellular matrix molecules on the tensile integrity of articular cartilage, the speci-
mens were extracted with 4 M guanidine HCl (Gnd), a strong chaotrophic agent
[47]. The maximum amount of GAG, as measured by hexuronate content, that
can be extract with Gnd is 85% of total, while the residual 15% remains behind
with the insoluble matrix [48]. To investigate the effects of Gnd on tensile proper-
ties apart from the effect on Gnd-induced matrix depletion alone, Gnd extracted tis-
sue was mechanically tested under associative conditions (in PBS) and under
dissociative conditions (in Gnd). Blocks of bCALF and bYOUNG, as well as hTEEN
and hADULT cartilage were treated (600 ll/block, 48 h, 4 C, pH 7.0), rinsed
(200 ll/block, 30 min, 22 C, pH 7.0), and mechanically tested in treat/rinse/test
combinations: (1a) PBS/PBS/PBS (sham control), (1b) Gnd/PBS/PBS, or (1c) Gnd/
Gnd/Gnd.
Experiment 2
While Gnd is a relatively non-speciﬁc depletion agent, more speciﬁc enzymatic
tissue digestions [49] were used with bCALF specimens. Chondroitinase ABC (C-
ABC) depolymerizes chondroitin sulfate (CS) and dermatan sulfate (DS) and, to
some degree, hyaluronic acid (HA) [10], thus potentially affecting CS and DS-con-
taining molecules such as aggrecan, decorin, and collagen type IX as well as HA.
Depending on the extent of HA cleavage, C-ABC may also affect proteoglycan aggre-
gates, as some of the aggregates which are attached to small HA fragments, may be
able to diffuse out of the tissue. Collagen and collagen network arrangement are
generally unaffected by C-ABC treatment [50–52]. Chondroitinase AC II (C-AC) is
more speciﬁc than C-ABC in that it catalytically cleaves CS and HA but not DS
[10]. Thus, C-AC may affect similar molecules as C-ABC, except DS-containing mol-
ecules like decorin. Streptomyces hyaluronidase (sHAase) splits HA [53] and, thus,
may remove some proteoglycan aggregates, similar to C-ABC and C-AC.
Explants from bCALF were subjected to either digestion with protease-free en-
zyme preparations or the corresponding sham solution (buffer solution that did not
contain the enzyme) treatment (0.1 ml/block, 24 h at 37 C): (2a) 0.2 U/ml C-ABC in
a buffer solution containing 0.05 M Tris buffer, pH 8.0, 0.01 M sodium acetate, and
0.02% BSA, (2b) 0.1 U/ml C-AC in a buffer solution containing 0.033 M acetic acid/
sodium acetate buffer, pH 6.0, and 0.01% BSA, (2c) 10 TRU/ml sHAase in a buffer
solution containing 0.02 M acetic acid/sodium acetate buffer, pH 6.0, and 0.15 M
NaCl. After treatment, the samples were washed and mechanically tested in PBS.
C-ABC, C-AC, and sHAase were from Seikagaku America (East Falmouth, MA).
The effects of Gnd on bCALF tissue were also examined further. To investigate
whether the effects of PBS wash of Gnd-treated blocks (as in 1b) are reversible
(i.e. if interactions that form in PBS, under associative conditions, are covalent)
the blocks were transferred to Gnd (dissociative conditions) and tested as such:
(2d) Gnd/PBS/Gnd. To investigate if the effects of Gnd on tensile properties depend
on extraction of matrix components, bCALF tissue was incubated in Gnd saturated
with cartilage extract (Gnd+), solution that allows incubation under dissociative
conditions without extracting matrix components: (2e) (Gnd+)/PBS/PBS. To prepare
Gnd+, articular cartilage from bCALF stiﬂe joints was ﬁnely minced (1–3 mm3
pieces) and incubated in Gnd (48 h, 4 C, pH 7.0) in a ratio of cartilage to Gnd of
2:1. The resulting Gnd+ (i.e. liquid portion) was ﬁltered through gauze and used
immediately.
Biochemical analysis
Residual cartilage and the failed portions of the corresponding tensile strip (see
below) were analyzed together to quantify the biochemical composition of the sam-
ples. Samples were solubilized with proteinase K [54] and analyzed to quantify the
content of sulfated GAG [55] and hydroxyproline [56]. In experiment 1, portions of
tissue digest from each animal or donor/layer and certain experimental conditions
were pooled for analysis of HA (Corgenix Inc., Denver, CO) and pyridinoline (PYR)
[57]. In experiment 2, HA content was determined for individual samples. Hydroxy-
proline content was converted to COL content by assuming a mass ratio of collagen
to hydroxyproline equal to 7.25 for bovine cartilage [58,59] and 7.1 for human car-
tilage [60]. The molar ratio of PYR per collagen molecule was calculated, assuming
the molecular weight of collagen triple helix of 300,000. Biochemical parameters
were normalized to initial wet weight of the tissue (WWi) to represent constituent
content.
Biomechanical analysis
Tapered tensile specimens were analyzed to determine mechanical properties
as described previously [54]. From each cartilage block, a tapered strip [61] with
a gage region of 4 mm  0.80 mm was prepared using a punch. The thickness of
each tensile strip was measured at three locations in the gage region and the aver-
age was used for cross-sectional area calculations. Tapered specimens were then se-
cured in clamps (4.0 mm apart) of a mechanical tester. The test sequence consisted
of applying a positive displacement at 0.5 mm/min until a tare load of 0.05 N
(equivalent to a stress of 0.2 MPa) was attained, then elongating the specimen
to 10% strain (relative to the length at the tare load) at a constant strain rate of
0.25%/s, allowing stress relaxation to equilibrium over 900 s, elongating the speci-
men to 20% strain, allowing stress relaxation to equilibrium over 900 s, and then
elongating the specimen at a constant rate of 5 mm/min until failure.
The measured load and displacement were converted to stress (deﬁned as load
normalized to the initial cross-sectional area of the gage region) and strain (deﬁned
as the elongation distance normalized to the initial clamp to clamp distance). The
equilibrium tensile modulus was calculated as the slope of the equilibrium
stress–strain data by linear regression. Tensile ramp modulus was calculated from
the last part of the mechanical test (elongation to failure) as the slope of the linear
regression of the stress–strain curve between 25% and 75% of the maximum stress.
Tensile strength was determined as the maximum stress sustained at failure, and
strain at failure was determined as the strain at which maximum stress was at-
tained. Blocks that were tested in Gnd fractured during the tare phase of the test.
Tensile ramp modulus was calculated as the slope of the linear regression of the
stress–strain curve for tare phase of the test and equilibrium modulus was calcu-
lated by multiplying the calculated ramp modulus by the average ratio of equilib-
rium to ramp modulus for blocks tested in PBS of the same layer. The failed
portions of each tensile strip, resulting from the tensile test, were saved for bio-
chemical analysis (described above) in addition to the adjacent cartilage samples
obtained during preparation of the tensile strips.
Statistical analysis
For each maturation stage/species (bCALF, bYOUNG, hTEEN, and hADULT) and
each layer (S and M), the effects of experimental conditions were assessed by anal-
ysis of variance (ANOVA) with experimental condition as ﬁxed factor and animal/
human donor as a random factor. For the content of HA, which was determined
from a pool of samples, the effects of experimental conditions were assessed by AN-
OVA for each maturation stage/species with experimental conditions and layer as
ﬁxed factors and donor animal as a random factor. Tukey post-hoc testing was per-
formed to compare groups. Data for equilibrium modulus of bCALF blocks in Figs. 1
and 4 were log-transformed to improve normality. To analyze the effect of experi-
mental conditions on wet weight, repeated measures ANOVA was performed for
each layer and experimental condition with wet weight (WWi, WWf) as a repeated
Fig. 1. Effect of experimental conditions on composition and tensile mechanical properties of bCALF (A–F), bYOUNG (G–L), hTEEN (M–R), and hADULT (S–X) articular
cartilage explants from S and M layers. Blocks were incubated (48 h at 4 C), rinsed and mechanically tested in combinations of PBS and Gnd. *Indicates p < 0.05 vs. PBS/PBS/
PBS control for a corresponding layer. Data are mean ± SEM or ±5% CI, n = 12–16 blocks from three bCALF animals, n = 12–15 block from three bYOUNG animals, n = 10–12
blocks from two hTEEN donors, and n = 14–18 blocks from three hADULT donors.
factor. Data are expressed as mean ± SEM or mean ±5% CI, where applicable, and
signiﬁcance level was set to 0.05. Statistical analysis was performed using Systat
10.2 (Systat Software Inc., Richmond, CA).
Results
Experiment 1
Treatment of bovine and human cartilage with Gnd did not af-
fect thickness of cartilage blocks (p > 0.16) and, consistent with
this, changes in tissue wet weight were minimal (data not shown).
In bCALF and bYOUNG cartilage, incubation in PBS did not change
tissue wet weight (p > 0.12), but during incubation in Gnd tissue
wet weight decreased slightly (7.4% to 10.2%, p < 0.001). In
hTEEN and hADULT cartilage, both incubation in PBS and Gnd de-
creased tissue wet weight (1.3% to 3.2% in PBS and 2.8% to
8.2% in Gnd; p < 0.01), but such decrease was generally larger
after incubation with Gnd than in PBS.
Gnd treatment affected biochemical composition of cartilage
blocks from bCALF, bYOUNG, hTEEN, and hADULT. Gnd treatment
released 70–85% (p < 0.001) of GAG (Fig. 1A, G, M, and S), with little
effect on collagen content (<5% release, p > 0.13) (Fig. 1B, H, N, and
T). Gnd treatment also reduced the content of HA in bCALF and bY-
OUNG tissue (17–20%, p < 0.05) (Fig. 2A and B) and slightly in
hTEEN and hADULT tissue (16–22%, p > 0.16) (Fig. 2C and D).
Experimental conditions affected the tensile biomechanical
properties of cartilage explants from bCALF, bYOUNG, and hTEEN,
but not hADULT. Depletion of matrix with Gnd and then rinse/test
in PBS markedly affected bCALF cartilage, with increased equilib-
rium modulus (775–1176%, p < 0.001) (Fig. 1C), ramp modulus
(189–199%, p < 0.001) (Fig. 1D) and strength (44–148%, p < 0.001)
(Fig. 1E) and a decrease in strain at failure (28% to 43%,
p < 0.05) (Fig. 1F), and moderately affected bYOUNG cartilage with
a slightly increased equilibrium modulus (105–120%, p < 0.05)
(Fig. 1I) and ramp modulus (37% in S, p < 0.05; 33% in M,
p = 0.18) (Fig. 1J), but not strength (p > 0.14) (Fig. 1K) and strain
at failure (p > 0.28) (Fig. 1L). In contrast, such treatment did not af-
fect tensile integrity of hTEEN (p > 0.25) (Fig. 1O–R) or hADULT
(p > 0.16) (Fig. 1U–X) cartilage.
Depletion of matrix with Gnd and then rinse/test in Gnd mark-
edly affected bCALF cartilage, with decreased equilibrium modulus
(77% to 93%, p < 0.001) (Fig. 1C), ramp modulus (82% to 92%,
p < 0.001) (Fig. 1D), strength (94%, p < 0.001) (Fig. 1E), and
strain at failure (49% to 58%, p < 0.05) (Fig. 1F), as well as bY-
OUNG cartilage with decreased equilibrium modulus (86% to
92%, p < 0.05) (Fig. 1I), ramp modulus (88% to 93%,
p < 0.001) (Fig. 1J), and strength (74% to 89%, p < 0.001)
(Fig. 1K) but not strain at failure (p > 0.30) (Fig. 1L). Such treatment
affected hTEEN cartilage, but only moderately, with decreased
equilibrium modulus (57%, p < 0.01) (Fig. 1O), ramp modulus
(45% to 53%, p < 0.05) (Fig. 1P), but not strength (p > 0.28)
(Fig. 1Q) and a slight increase in strain at failure (32–52%,
p < 0.05) (Fig. 1R). In contrast, such treatment did not affect tensile
integrity of hADULT cartilage (p > 0.13) (Fig. 1U–X).
The maturity of the source tissue, as indicated by tissue age,
agreed with measures of content of collagen, PYR crosslinks, and
PYR/COL ratio, parameters that are sensitive to the degree of tissue
maturity [45]. The content of collagen and PYR crosslinks, and PYR/
COL ratio were low in bCALF tissue and increased with growth to
bYOUNG tissue (Figs. 1B, H and 5). In hTEEN and hADULT cartilage,
the contents of collagen, PYR crosslinks and PYR/COL ratio were
higher than those of bCALF and bYOUNG cartilage (Figs. 1N, T
and 5).
Experiment 2
Enzymatic treatment of bCALF cartilage did not affect thickness
of cartilage blocks (p > 0.26) and, consistent with this, changes in
tissue wet weight were minimal (data not shown). Incubation in
sham solutions did not change tissue wet weight in the S layer
(p > 0.13) and increased wet weight slightly in the M layer (up to
3%, p < 0.001), while during incubation in solutions containing C-
ABC, C-AC, and sHAase tissue wet weight decreased (7.5% to
10.5%, p < 0.001). Similar to effects of Gnd on tissue wet weight
in experiment 1, incubation in Gnd decreased tissue wet weight
slightly (7.4% to 10.2%, p < 0.001), while during incubation in
PBS and Gnd+, tissue wet weight remained unchanged (p > 0.08)
(data not shown).
The effects of treatments with C-ABC, C-AC, and sHAase of
bCALF blocks were similar to the effect of Gnd, in terms of both
biochemical and biomechanical parameters. C-ABC, C-AC, and sHA-
ase treatments released 95%, 95%, and 63% of GAG (p < 0.001)
(Fig. 3A, H, and O), and 64%, 85%, and 87% of HA (p < 0.001)
(Fig. 3B, I, and P), respectively, with little effect on collagen content
(<5% release, p > 0.17) (Fig. 3C, J, and Q). Depletions of tissue matrix
with C-ABC, C-AC, and sHAase and subsequent rinse/test in PBS re-
sulted in a marked increase in equilibrium modulus (246–782%,
p < 0.01) (Fig. 3D, K, and R), ramp modulus (149–373%, p < 0.01)
(Fig. 3E, L, and S) and strength (80–300%, p < 0.05) (Fig. 3F, M,
and T). The strain at failure did not vary or decreased after enzy-
matic treatment (up to 45%, p > 0.05) (Fig. 3G, N, and U).
Further investigation of the effect of Gnd on bCALF tissue agreed
with ﬁndings of experiment 1 on both biochemical and biome-
chanical parameters and yielded more information about the nat-
ure of the effects of ECM depletion. Gnd treatment released 85%
(p < 0.001) of GAG (Fig. 4A), with little effect on collagen content
(<5% release, p > 0.30) (Fig. 4B). In contrast, incubation in Gnd+
did not affect biochemical parameters, with GAG and COL similar
to those in tissue incubated in PBS (p > 0.99). Similar to effects of
Fig. 2. Effect of Gnd treatment on the content of hyaluronic acid (HA) of bCALF (A), bYOUNG (B), hTEEN (C), and hADULT (D) articular cartilage explants from S and M layers.
Blocks were incubated (48 h at 4 C), rinsed and mechanically tested in PBS or Gnd. indicates p < 0.05 vs. PBS/PBS/PBS control for both layer collectively. Data are
mean ± SEM, n = 12–16 blocks from three bCALF animals, n = 12–15 block from three bYOUNG animals, n = 10–12 blocks from two hTEEN donors, and n = 14–18 blocks from
three hADULT donors.
Gnd on biomechanical properties in experiment 1, depletion of ma-
trix with Gnd and then rinse/test in PBS resulted in a marked in-
crease in equilibrium modulus (530–736%, p < 0.001) (Fig. 4C),
ramp modulus (246–295, p < 0.001) (Fig. 4D) and strength (63–
178%, p < 0.05) (Fig. 4E) and a decrease in strain at failure (38%
in S, p = 0.12; 48% in M, p < 0.001) (Fig. 4F), and depletion of ma-
trix with Gnd and then rinse/test in Gnd resulted in a decrease in
equilibrium modulus (77% to 90%, p < 0.05) (Fig. 4C), ramp
modulus (78% to 90%, p < 0.05) (Fig. 4D), strength (95%,
p < 0.05) (Fig. 4E), and strain at failure (60%, p < 0.05) (Fig. 4F).
Incubation in Gnd, with a PBS rinse, and subsequent test in Gnd, re-
sulted in a decreased equilibrium modulus (59% to 86%,
p < 0.05) (Fig. 4C), ramp modulus (68% to 86%, p < 0.05)
(Fig. 4D), strength (93%, p < 0.05) (Fig. 4E), and strain at failure
(48% in S, p = 0.13; 60% in M, p < 0.001) (Fig. 4F), and these
mechanical properties approximated those of Gnd-treated tissue
tested in Gnd but not exposed to PBS (p > 0.39). Finally, incubation
in Gnd+ restored mechanical properties to native levels, with equi-
librium and ramp moduli, strength, and strain at failure similar to
those of tissue incubated and tested in PBS (p > 0.93) (Fig. 4C–F).
Fig. 3. Effect of experimental conditions on composition and tensile mechanical
properties of bCALF articular cartilage explants from S and M layers. Blocks were
incubated (24 h at 37 C) in either C-ABC (A–G), C-AC (H–N), sHAase (O–U) or a
corresponding sham buffer (-) and mechanically tested in PBS. *Indicates p < 0.05
vs. sham control for a corresponding layer. Data are mean ± SEM, n = 4–6 blocks.
Fig. 4. Effect of experimental conditions on composition and tensile mechanical
properties of bCALF articular cartilage explants from S and M layers. Blocks were
incubated (48 h at 4 C), rinsed and mechanically tested in combinations of PBS,
Gnd, and Gnd saturated with cartilage extract (Gnd+). *Indicates p < 0.05 vs. PBS/
PBS/PBS control for a corresponding layer. Data are mean ± SEM or ±5% CI, n = 4–6
blocks.
Discussion
The data presented here demonstrate that tensile mechanical
properties of articular cartilage can be modulated through deple-
tion of certain extracellular matrix components; however the ex-
tent of this modulation is dependent on the maturity of the
source tissue. In immature bovine cartilage (bCALF), matrix deple-
tion with Gnd resulted in a marked enhancement of tensile integ-
rity when mechanically tested under associative conditions in PBS
and a marked decrease in tensile integrity when mechanically
tested under dissociative conditions in Gnd (Fig. 1C–E). The en-
hanced tensile integrity of immature cartilage after matrix deple-
tion and testing in PBS suggests that certain ECM components of
immature matrix serve to inhibit CN interactions that promote ten-
sile integrity, while reduction of tensile integrity to very low levels
after depletion and testing in Gnd indicates that certain endoge-
nous linkages within the CN can be disrupted by Gnd. As the tissue
maturity increases (from bCALF to bYOUNG to hTEEN to hADULT),
a progressively more moderate enhancement of tensile integrity
after matrix depletion in Gnd and testing under associative condi-
tions in PBS and less marked diminution of tensile integrity after
matrix depletion in Gnd and testing under dissociative conditions
in Gnd is observed, until hADULT tissue that is not affected by ma-
trix depletion with Gnd (Fig. 1). The lack of effect of matrix deple-
tion with Gnd on tensile integrity in hADULT cartilage suggests
that in mature human cartilage tissue, the CN attains a state in
which further tensile integrity-promoting interactions can not be
induced by removing matrix molecules and that the endogenous
linkages within the CN can not be disrupted by Gnd.
The effects of increasingly selective enzymatic treatments of
bCALF tissue, along with further examination of the effects of
Gnd, provide insight into the nature of the modulated CN interac-
tions that promote tensile integrity after matrix depletion. For
bCALF, the effects of treatments with C-ABC, C-AC, and sHAase
were similar to the effects of Gnd both in terms of biochemical
and biomechanical parameters (Figs. 1A–F and 3). This result, along
with substrate speciﬁcity of C-ABC, C-AC, and sHAase, may allow
the identiﬁcation of ECM molecules that serve to inhibit CN inter-
actions that form as a result of matrix depletion. The decrease in
tensile integrity in Gnd-treated and PBS-rinsed bCALF tissue tested
in Gnd to levels similar to those observed in tissue tested in Gnd
but not exposed to PBS (Fig. 4C–E) indicates that the effects of
PBS rinse on the tensile integrity were reversible, suggesting that
CN interactions involved in the remodeling of the CN in response
to matrix depletion are not covalent. Therefore, the enhancement
of tensile integrity after matrix depletion does not involve the for-
mation of collagen crosslinks. In addition, the lack of effects on bio-
chemical composition and tensile integrity of incubation in Gnd+
conﬁrms that the formation of modulated, tensile integrity-pro-
moting CN interactions is dependent on the depletion of certain
matrix components.
The use of bovine and human cartilage explants for studying
maturation-dependent modulation of CN and cartilage tensile
properties required consideration of a number of issues. Both bo-
vine and human cartilage was examined to represent different
states of maturity of cartilage tissue. While examining a range of
maturation states from one species would be desirable it could
not be implemented for practical issues. Bovine tissue older than
1–2 years old could not be examined because of difﬁculty ﬁnding
joints that were macroscopically normal, while human tissue from
donors younger than 15 years old could not be examined because
of supply limitations. The tissue was harvested in layers, using the
top 1 mm of articular cartilage. Because the various zones of nor-
mal cartilage exhibit differences in biochemical composition and
mechanical properties, both superﬁcial and middle layer were ana-
lyzed. The patellofemoral groove of bovines was used as the source
of tissue, similar to tissue used in previous studies [45,54,62]. Con-
sequently, the biochemical and biomechanical properties of bCALF
and bYOUNG tissue samples examined after incubation and testing
in sham conditions were similar to those reported previously
[45,54]. The tensile specimens of human cartilage were also taken
from patellofemoral groove, based on preliminary studies that
showed little variation among specimens from this location for
an individual joint. Biochemical and biomechanical parameters of
hTEEN and hADULT tissue examined after incubation and testing
in PBS were generally similar to those reported previously for hu-
man cartilage [17,63].
Immature cartilage can be rendered stiff or soft experimentally
by alterations in the tissue matrix through enzymatic or chemical
treatments, suggesting that the restraining function of the CN can
be regulated through interactions of components of the extracellu-
lar matrix. Studies of collagen molecules in vitro as well of tendon
in vitro and in vivo indicate that additional interactions or interac-
tions of a different type may occur among collagen ﬁbrils after
depletion of certain matrix molecules. Enzymatic treatment with
trypsin, which may remove at least some of the collagen-coating
small proteoglycans, appears to enhance the association of colla-
gen ﬁbrils from tendon in vitro [39], while treatment of tendon ex-
plants with C-ABC results in reduced propensity to swell and
enhanced tensile strength [16]. In addition, during embryonic ten-
don growth, a dramatic decrease in ﬁbril-associated decorin occurs
contemporary with lateral collagen ﬁbril fusion to form more con-
tinuous ﬁbrils [37]. The reduced tensile integrity of bCALF tissue
after matrix depletion with Gnd, similar to the reduction in tensile
strength observed after 1 M Gnd treatment in sea urchin ligament
[64], indicates the importance of the non-covalent endogenous
interaction among matrix components in cartilaginous tissues.
Certain components of the extracellular matrix may be respon-
sible for controlling the stiffness and the restraining function of the
collagen network through mediating the adherence and sliding be-
tween collagen ﬁbrils. It has been proposed that the collagen ﬁ-
brils, or groups of ﬁbrils, slide past one another mediating the
response of cartilaginous tissues to mechanical loading and modu-
lating tissue length/shape. The deﬂection patterns of lines photo-
bleached or ﬂuorescently stained into the extracellular matrix
suggest that collagen sliding occurs in rat tendon and ligament
and bovine annulus ﬁbrosis [32,33,65]. The presence of gaps within
transversely sectioned ﬁbril bundles in electron micrographs of
Fig. 5. The content of pyridinoline crosslinks (PYR) and molar ratio of PYR to col-
lagen (PYR/COL) in of bCALF, bYOUNG, hTEEN, and hADULT articular cartilage ex-
plants from S and M layers. Blocks were incubated (48 h at 4 C), rinsed and
mechanically tested in PBS. Data are mean ± SEM, n = 12–16 blocks from three b-
CALF animals, n = 12–15 block from three bYOUNG animals, n = 10–12 blocks from
two hTEEN donors, and n = 14–18 blocks from three hADULT donors.
experimentally elongated sea urchin ligament, is also indicative of
ﬁbril sliding [64]. It is possible that if molecules that mediate slid-
ing are removed, collagen ﬁbrils can associate linearly (end-to-end)
or laterally (side-to-side) to increase the ﬁbril diameter and conse-
quently increase tensile stiffness and strength of the tissue overall
[38,39,66]. Conversely, if the endogenous linkages within the CN
are disrupted, sliding can be enhanced resulting in a decrease in
tensile integrity.
While the enhanced tensile integrity of immature cartilage after
matrix depletion suggests the involvement of different interactions
between collagen ﬁbrils within the collagen network, some of the
increase in the overall tensile integrity after matrix depletion dem-
onstrated in this study and observed by others [13,14] can be ex-
plained by direct individual contributions of GAG and the
collagen network components to the tensile properties of cartilage.
In normal cartilage, proteoglycans act to inﬂate the collagen net-
work and establish a level of pre-stress [67], while in matrix-de-
pleted cartilage, in the absence of pre-stress, the collagen
network would be expected to relax and straighten. Although ma-
trix depletion did not affect thickness and had little effects on tis-
sue wet weight, the small decrease in wet weight due to treatment
may indicate a contraction of the collagen network. The absence of
pre-stress in the collagen network of treated cartilage may contrib-
ute to a higher strength, while collagen network straightening can
account for some of the decrease in failure strain and, conse-
quently, an increase in the ramp stiffness/modulus. Thus, although
the tensile behavior of cartilage in the high strain region is gener-
ally attributed to the tensile response of the collagen network
[11,45], these results demonstrate an indirect, but dramatic, con-
tribution of the proteoglycan component.
The extent of modulation of tensile integrity by matrix deple-
tion was dependent on the stage of maturity of the source tissue
and may reﬂect the intrinsic tissue function at a certain maturation
stage. In the bCALF tissue, tensile integrity could be markedly in-
creased or decreased resulting in a fairly large range of modulated
tissue state. As the tissue maturity increases, from bCALF to bY-
OUNG to hTEEN to hADULT, a progressively smaller range of mod-
ulated tissue states was observed, until hADULT tissue that was not
affected by matrix depletion. It is possible that a relatively lax tis-
sue state that allows modulation of the CN integrity is associated
with an immature and growing tissue which needs to remodel as
it rapidly increases in size during growth. As the tissue matures,
the need to grow decreases and the need to bear load increases
to reach a more rigid tissue state desired in adulthood. The trans-
formation of cartilage tissue from the lax immature to a rigid ma-
ture state may involve regulation of CN integrity through alterable
interactions of matrix components. For example, the increase in
tensile integrity that occurs during growth of bovine cartilage
in vivo from bCALF to bYOUNG (Fig. 1C–E and I–K), can be attained
in bCALF tissue with matrix depletion alone. The residual varia-
tions between the modulated integrity of bCALF tissue and native
integrity of bYOUNG tissue may be due to changes in the content
of other ECM components, such as collagen and PYR crosslinks
(Figs. 1B, H and 5).
Increasingly selective matrix depletion of bCALF cartilage with
Gnd, C-ABC, C-AC, and sHAase may provide insights into the iden-
tity of molecules that may serve to inhibit the tensile integrity-pro-
moting interactions in the immature tissue. Considering
extraﬁbrillar matrix molecules such as aggrecan, collagen IX, deco-
rin, and ﬁbromodulin as candidate ‘‘inhibitory” molecules, and the
ﬁnding that tensile integrity-promoting interactions form when
matrix molecules are removed, molecules that are unaltered by a
certain treatment are excluded from the list of potential candi-
dates. Treatment with Gnd extracts matrix molecules that are
not linked to the CN covalently [48], thereby ruling out collagen
IX as it is covalently attached to collagen II ﬁbrils [18]. The involve-
ment of ﬁbromodulin is also excluded, as treatment with C-ABC
does not affect keratan sulfate content of cartilage [50]. While
aggrecan contains most of tissue’s C-ABC-susceptible material,
depletion of GAG with C-ABC may alter or displace other chondroi-
tin sulfate- or dermatan sulfate-containing molecules such as col-
lagen type IX and decorin. The involvement of decorin, however, is
excluded as treatment with C-AC does not remove this molecule
[10], but resulted in enhancement of tensile integrity similar to
that produced by C-ABC treatment. Treatment with sHAase was
the most selective as sHAase susceptible material includes HA
[53] and, consequently, may also involve proteoglycan aggregates,
suggesting that these molecules are the primary candidates as the
‘‘inhibitory” components in the immature tissue. While aggrecan is
the primary candidate to serve as such ‘‘inhibitory” component,
other matrix molecules that are not considered here may also be
involved. To further conﬁrm aggrecan as the inhibitory molecule,
it can be tested as a monomer or with other molecules, such as
HA, through depletion/repletion studies.
While the exact nature of the interactions of matrix compo-
nents within cartilage tissue remains to be established, these ﬁnd-
ings may have a practical utility for tissue engineering of cartilage
tissue grafts for the purposes of repairing articular cartilage de-
fects. Since the tensile integrity-promoting interactions in imma-
ture tissue are non-covalent, it may be possible to deconstruct
and reconstruct the constituents to modulate CN function. Identi-
ﬁcation of methods to reconstruct constituents, may allow the
assembly of desired components that would enhance functional
properties of cartilage tissue, thus producing a mature tissue con-
struct in a short time period.
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